MKS Positioned for 2026-27 Earnings Rebound Despite Q4 Falling Short of Expectations, Morgan Stanley Says

MT Newswires Live02-20

MKS (MKSI) remains well positioned for a strong earnings recovery into 2026 and 2027 despite a Q4 report that fell short of "sky high expectation," Morgan Stanley said in a report Wednesday.

Although MKS' Q1 revenue guidance of about $1.04 billion slightly missed the $1.05 billion consensus estimate, the investment bank said the long-term thesis remains intact. "Strong" E&P tool bookings, improving gross margin trends and expected semiconductor outperformance in a Wafer Fabrication Equipment recovery support a favorable 2026 to 2027 setup, the report said.

The investment bank said the June quarter could prove significant, forecasting 6.7% sequential revenue growth, up from a prior 3.5% estimate. Semiconductor revenue has exceeded the midpoint of guidance by an average of 4% "over the past five quarters," aided by customer pull-ins late in the quarter, a trend expected to continue, according to the report.

Morgan Stanley has raised fiscal-year 2026 revenue and EPS estimates to $4.56 billion and $10.44, respectively, and fiscal-year 2027 projections to $5.28 billion and $14.27, citing stronger growth assumptions in both semi and electronics & packaging markets.

Morgan Stanley has an overweight rating on MKS and raised its price target to $300 from $258.

Price: 248.83, Change: -1.54, Percent Change: -0.61

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment